Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析

◆英語タイトル:Provectus Biopharmaceuticals Inc (PVCT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82168FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals Inc Key Recent Developments

Mar 30,2021: Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office
Mar 23,2021: Provectus Biopharmaceuticals Receives Notice of Allowance for Refractory Pediatric Solid Tumor Cancer Monotherapy and Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office
Jul 16,2020: Provectus Biopharmaceuticals announces change to Board of Directors

This comprehensive SWOT profile of Provectus Biopharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Provectus Biopharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Provectus Biopharmaceuticals Inc – Key Information
Provectus Biopharmaceuticals Inc – Overview
Provectus Biopharmaceuticals Inc – Key Employees
Provectus Biopharmaceuticals Inc – Key Employee Biographies
Provectus Biopharmaceuticals Inc – Key Operational Heads
Provectus Biopharmaceuticals Inc – Major Products and Services
Provectus Biopharmaceuticals Inc – History
Provectus Biopharmaceuticals Inc – Company Statement
Provectus Biopharmaceuticals Inc – Locations And Subsidiaries
Provectus Biopharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Provectus Biopharmaceuticals Inc – Business Description
Provectus Biopharmaceuticals Inc – Corporate Strategy
Provectus Biopharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Provectus Biopharmaceuticals Inc – Strengths
Provectus Biopharmaceuticals Inc – Weaknesses
Provectus Biopharmaceuticals Inc – Opportunities
Provectus Biopharmaceuticals Inc – Threats
Provectus Biopharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Provectus Biopharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Provectus Biopharmaceuticals Inc, Key Information
Provectus Biopharmaceuticals Inc, Key Ratios
Provectus Biopharmaceuticals Inc, Share Data
Provectus Biopharmaceuticals Inc, Major Products and Services
Provectus Biopharmaceuticals Inc, History
Provectus Biopharmaceuticals Inc, Key Employees
Provectus Biopharmaceuticals Inc, Key Employee Biographies
Provectus Biopharmaceuticals Inc, Key Operational Heads
Provectus Biopharmaceuticals Inc, Other Locations
Provectus Biopharmaceuticals Inc, Subsidiaries
Provectus Biopharmaceuticals Inc, Key Competitors
Provectus Biopharmaceuticals Inc, SWOT Analysis
Provectus Biopharmaceuticals Inc, Ratios based on current share price
Provectus Biopharmaceuticals Inc, Annual Ratios
Provectus Biopharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lassonde Industries Inc.:戦略・SWOT・企業財務分析
    Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sberbank of Russia:企業のM&A・事業提携・投資動向
    Sberbank of Russia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sberbank of Russia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • PolyNovo Ltd (PNV):医療機器:M&Aディール及び事業提携情報
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company provides products such as biodegradable temporizing matrix and negative pressure wound therapy dressing sys …
  • BioHorizons Inc-医療機器分野:企業M&A・提携分析
    Summary BioHorizons Inc (BioHorizons), a subsidiary of Henry Schein Inc is a medical device company that manufactures and develops dental products. The company’s products include dental implants, short implants, guided surgery kits, and others. It provides overdentures, gum grafting and bone graftin …
  • Gulfport Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Gulfport Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Gulfport Energy Corp (Gulfport) is an oil and gas company that explores, develops and produces oil and natural gas. The company operates its oil and gas exploration and development assets in Uti …
  • China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析
    China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析
    Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Entia Biosciences Inc (ERGO):企業の財務・戦略的SWOT分析
    Summary Entia Biosciences Inc (EBI) is a biotechnology company that provides nutrigenomics solutions for organic health, beauty and agriculture. The company’s solution includes ErgoD2, mushroom dietary supplement, and multi joint support. It offers ErgoD2 solutions such as Ergo-D2-Hemo, Ergo-D2-FLEX …
  • Leoni AG (LEO):企業の財務・戦略的SWOT分析
    Leoni AG (LEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • Ray Sigorta A.S.:企業の戦略・SWOT・財務情報
    Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report Summary Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析
    Summary Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and …
  • Rafako SA (RFK):電力:M&Aディール及び事業提携情報
    Summary Rafako SA (Rafako), a subsidiary of PBG SA is a power generation equipment manufacturer that designs and distributes boilers and environment protection units. The company provides a range of boilers such as PC boilers, circulating fluidized bed (CFB) boilers, heat recovery steam generator (H …
  • Singulex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Buckeye Partners LP (BPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Buckeye Partners LP (Buckeye) is a provider of midstream logistic solutions. It owns and operates a diversified network of integrated assets for the transportation, storage, processing and marketing of liquid petroleum products. The company transports liquid petroleum products, including gas …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CytoSorbents Corp (CTSO):医療機器:M&Aディール及び事業提携情報
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Orexo AB (ORX):企業の財務・戦略的SWOT分析
    Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆